Data completeness
2/8 — Basic
ATHROMBIN (warfarin sodium) by Molecular Devices is k-dependent clotting factors, which include factors ii, vii, ix, and x, and the anticoagulant proteins c and s. Approved for atrial fibrillation, left ventricular thrombosis, liver cirrhosis.
Drug data last refreshed 2w ago
Mechanism of Action
K-dependent clotting factors, which include Factors II, VII, IX, and X, and the anticoagulant proteins C and S. Vitamin K is an essential cofactor for the post ribosomal synthesis of the vitamin K-dependent clotting factors. Vitamin K promotes the biosynthesis of γ-carboxyglutamic acid residues in…
Worked on ATHROMBIN at Molecular Devices? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.